With four new therapies making their way to the previously arid treatment landscape of acute myeloid leukemia (AML),1 it’s an exciting time for people affected by the disease.
As part of our special AML World Awareness Day coverage, we brought together some leading figures in AML advocacy to discuss using collaboration to overcome awareness, education and access challenges.
The webinar, Knowledge is power – using education and awareness to drive positive change for patients, included Dr. Gwen Nichols, Chief Medical Officer of The Leukemia & Lymphoma Society, Kathleen Weis, Chief Executive Officer of the Aplastic Anemia and MDS International Foundation, Gary Nolan, Know AML secretariat member, and Brian Tomlinson, Know AML patient advocate ambassador and Chief Program Officer at CancerCare.
In a session that offered plenty of tips, advice and insight relevant to the whole patient advocacy community, they spoke about:
- How partnership working is translating laboratory findings into the clinic
- How advocacy groups can move quickly to address the changing educational needs of the people they serve
- How the global pooling of resources is driving education and awareness like never before
Watch the full webinar below.
- OncLive (2018). Novel Agents Advance Field of AML. Available from: https://www.onclive.com/web-exclusives/novel-agents-advance-field-of-aml (accessed May 2018).